Pfizer Inc -- Payments to Oncology Physicians

This page provides a detailed breakdown of Pfizer Inc's payments to Oncology physicians, as reported in the CMS Open Payments (Sunshine Act) database. Understanding how a pharmaceutical company targets specific medical specialties reveals important patterns about their marketing strategies and physician relationships.

Payment Summary: Pfizer Inc to Oncology

Why Does Pfizer Inc Pay Oncology Doctors?

Pharmaceutical companies make payments to physicians in specialties related to their product portfolio. Pfizer Inc's payments to Oncology specialists may include consulting fees for drug development advice, speaking engagements at medical conferences, clinical trial research funding, and meals during product education visits. The volume and types of payments to Oncology doctors can indicate the importance of this specialty to Pfizer Inc's business strategy.

Understanding the relationship between Pfizer Inc and Oncology physicians helps patients evaluate whether their doctor's prescribing patterns might be influenced by financial relationships with this company.

Payment Types: How Pfizer Inc Pays Oncology Doctors

The following table shows the breakdown of payment categories from Pfizer Inc to Oncology physicians:

Payment TypeTotal AmountTransactions
Ownership Interest$187,911.021
Research Funding$104,217.881
Consulting Fees$89,580.999
Speaking & Education$40,754.352
Travel & Lodging$14,817.074
general$10,769.808
Food & Beverage$922.298

Top Oncology Doctors Paid by Pfizer Inc

The following Oncology physicians have received the largest total payments from Pfizer Inc. Click on any physician to view their complete payment report.

PhysicianTotal ReceivedTransactions
Charles Baker$187,911.021
Benjamin Cook$104,217.881
Elizabeth Roberts$24,843.721
Christopher Clark$23,038.911
Rachel Parker$20,984.551
Michelle Scott$17,715.441
Brian Wright$14,978.641
John Anderson$8,946.631
Jeffrey Campbell$7,790.711
Catherine Morris$5,400.171
Amanda Lewis$4,707.741
Maria Martinez$4,331.401
Kevin Hill$3,866.891
Karen Harris$3,420.471
Susan Taylor$2,579.581
Maria Martinez$2,488.661
Steven Green$2,354.821
Joseph Carter$2,020.001
Richard Brown$1,911.041
Emily Thompson$1,413.651

Recent Payments from Pfizer Inc to Oncology Physicians

DoctorAmountTypeDrug/DeviceDate
Michael Rodriguez$104.66mealsN/A2026-03-29
Christopher Clark$23,038.91speakingN/A2026-03-10
Michelle Scott$17,715.44speakingN/A2026-03-08
Amanda Lewis$400.57generalN/A2026-03-01
Melissa Reed$436.77generalN/A2026-02-24
Benjamin Cook$104,217.88researchN/A2026-02-17
Maria Martinez$4,331.40travelN/A2026-02-15
Jeffrey Campbell$7,790.71consultingN/A2026-02-03
Karen Harris$3,420.47consultingN/A2026-01-28
Susan Taylor$2,579.58consultingN/A2026-01-28
Brian Wright$636.52consultingN/A2026-01-23
Brian Wright$14,978.64consultingN/A2026-01-16
Charles Baker$187,911.02ownershipN/A2026-01-15
Kevin Hill$3,866.89travelN/A2026-01-14
Christine Edwards$113.38mealsN/A2026-01-07

Frequently Asked Questions

How much does Pfizer Inc pay Oncology doctors?

According to CMS Open Payments data, Pfizer Inc has made $448,973.40 in payments to Oncology physicians across 33 transactions. The average payment is $13,605.25. These payments include consulting fees, speaking engagements, meals, research funding, and other transfers of value required to be reported under the Sunshine Act.

Which Oncology doctors receive the most from Pfizer Inc?

The top Oncology physician receiving payments from Pfizer Inc is Charles Baker, with $187,911.02 across 1 transactions. View the full ranking table above for all Oncology doctors paid by Pfizer Inc.

Why does Pfizer Inc target Oncology specialists?

Pharmaceutical companies target medical specialties related to their product portfolio. Pfizer Inc's payments to Oncology doctors likely relate to drugs or devices used in oncology practice. These payments can include advisory board fees, clinical trial funding, and educational speaking engagements.

Should I be concerned if my Oncology doctor takes money from Pfizer Inc?

Payment from Pfizer Inc to a Oncology physician does not imply wrongdoing. Many payments represent legitimate professional activities like research and medical education. However, patients may want to ask their doctor about these relationships, especially if Pfizer Inc products are being prescribed. Transparency helps patients have informed conversations with their physicians.

How does Pfizer Inc's Oncology spending compare to other pharma companies?

Pfizer Inc has spent $448,973.40 on Oncology physicians. To compare with other pharmaceutical companies, visit the Oncology specialty page for a broader view of which companies spend the most on this medical specialty.

Related Reports

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.